Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Jan 12;325(2):156-163.
doi: 10.1001/jama.2020.23718.

Association of Fresh Embryo Transfers Compared With Cryopreserved-Thawed Embryo Transfers With Live Birth Rate Among Women Undergoing Assisted Reproduction Using Freshly Retrieved Donor Oocytes

Affiliations
Comparative Study

Association of Fresh Embryo Transfers Compared With Cryopreserved-Thawed Embryo Transfers With Live Birth Rate Among Women Undergoing Assisted Reproduction Using Freshly Retrieved Donor Oocytes

Iris G Insogna et al. JAMA. .

Abstract

Importance: In in vitro fertilization cycles using autologous oocytes, data have demonstrated higher live birth rates following cryopreserved-thawed embryo transfers compared with fresh embryo transfers. It remains unknown if this association exists in cycles using freshly retrieved donor oocytes.

Objective: To test the hypothesis that in freshly retrieved donor oocyte cycles, a fresh embryo transfer is more likely to result in a live birth compared with a cryopreserved-thawed embryo transfer.

Design, setting, and participants: Retrospective cohort study using national data collected from the Society for Assisted Reproductive Technology for 33 863 recipients undergoing fresh donor oocyte cycles in the US between January 1, 2014 and December 31, 2017.

Exposures: Fresh embryo transfer and cryopreserved-thawed embryo transfer.

Main outcomes and measures: The primary outcome was live birth rate; secondary outcomes were clinical pregnancy rate and miscarriage rate. Analyses were adjusted for donor age, day of embryo transfer, use of a gestational carrier, and assisted hatching.

Results: Recipients of fresh and cryopreserved-thawed embryos had comparable median age (42.0 [interquartile range {IQR}, 37.0-44.0] years vs 42.0 [IQR, 36.0-45.0] years), gravidity (1 [IQR, 0-2] vs 1 [IQR, 0-3]), parity (0 [IQR, 0-1] vs 1 [IQR, 0-1]), and body mass index (24.5 [IQR, 21.9-28.7] vs 24.4 [IQR, 21.6-28.7]). Of a total of 33 863 recipients who underwent 51 942 fresh donor oocyte cycles, there were 15 308 (29.5%) fresh embryo transfer cycles and 36 634 (70.5%) cryopreserved-thawed embryo transfer cycles. Blastocysts were transferred in 92.4% of fresh embryo transfer cycles and 96.5% of cryopreserved-thawed embryo transfer cycles, with no significant difference in the mean number of embryos transferred. Live birth rate following fresh embryo transfer vs cryopreserved-thawed embryo transfer was 56.6% vs 44.0% (absolute difference, 12.6% [95% CI, 11.7%-13.5%]; adjusted relative risk [aRR], 1.42 [95% CI, 1.39-1.46]). Clinical pregnancy rates were 66.7% vs 54.2%, respectively (absolute difference, 12.5% [95% CI, 11.6%-13.4%]; aRR, 1.34; [95% CI, 1.31-1.37]). Miscarriage rates were 9.3% vs 9.4%, respectively (absolute difference, 0.2% [95% CI, -0.4% to 0.7%]); aRR, 0.98 [95% CI, 0.91-1.07]).

Conclusions and relevance: In this retrospective cohort study of women undergoing assisted reproduction using freshly retrieved donor oocytes, the use of fresh embryo transfers compared with cryopreserved-thawed embryo transfers was associated with a higher live birth rate. However, interpretation of the findings is limited by the potential for selection and confounding bias.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Insogna reported being employed part-time as an assistant physician for Teladoc Health compiling patient records for review by a consultant (the role involves no consultation). Dr Ginsburg reported serving as a writer, reviewer, and editor for UpToDate and BioMed Central and as a consultant for Teladoc Health. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Selection, Transfer Cycle Type, PGT-A, and Outcomes of Embryo Transfer Cycles Evaluated Through the Study
PGT-A indicates preimplantation genetic testing for aneuploidy; SART, Society for Assisted Reproductive Technology. aExclusions were not mutually exclusive. bThe American Society for Reproductive Medicine recommends that anonymous donors be between 21 and 34 years of age. All included cycles used only anonymous oocyte donors. Cycles that were missing documentation of donor age were included. A total of 337 (2.2%) fresh embryo transfer cycles and 17 694 (48.3%) cryopreserved-thawed embryo transfer cycles were missing donor age data.
Figure 2.
Figure 2.. Live Birth, Clinical Pregnancy, and Miscarriage Rates in Fresh and Cryopreserved-Thawed Embryo Transfers Derived From Freshly Inseminated Donor Oocytes With and Without PGT-A
These analyses were tested for the presence of an interaction, and the results for all outcomes were found not to be significant (live birth, P = .72; clinical pregnancy, P = .30; miscarriage, P = .17). aPreimplantation genetic testing (PGT-A) is the removal of 3 to 5 trophectoderm cells from a blastocyst to test the embryo for chromosomal aneuploidy prior to transfer. bAdjusted for donor age, day of embryo transfer, use of a gestational carrier, and assisted hatching.

Similar articles

Cited by

References

    1. Lutjen P, Trounson A, Leeton J, Findlay J, Wood C, Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature. 1984;307(5947):174-175. doi:10.1038/307174a0 - DOI - PubMed
    1. Centers for Disease Control and Prevention 2016 Assisted Reproductive Technology National Summary Report Published 2016. Accessed January 27, 2020. https://www.cdc.gov/art/reports/
    1. Kawwass JF, Monsour M, Crawford S, et al. ; National ART Surveillance System Group . Trends and outcomes for donor oocyte cycles in the United States, 2000-2010. JAMA. 2013;310(22):2426-2434. doi:10.1001/jama.2013.280924 - DOI - PMC - PubMed
    1. Society for Assisted Reproductive Technology Final National Summary Report for 2017. Accessed January 27, 2020. https://www.sartcorsonline.com/rptCSR_PublicMultYear.aspx?reportingYear=...
    1. Kushnir VA, Darmon SK, Barad DH, Gleicher N. New national outcome data on fresh versus cryopreserved donor oocytes. J Ovarian Res. 2018;11(1):2. doi:10.1186/s13048-017-0378-4 - DOI - PMC - PubMed

Publication types